Table 1.
Basic patient characteristics in women with HPV-associated and non-HPV-associated malignancies
| Cervical cancer (n = 30) | Vaginal & vulvar cancer (n = 21) | Ovarian cancer (n = 30) | Endometrial cancer (n = 30) | P | ||
|---|---|---|---|---|---|---|
| Age at the survey (years)* |
51.87 ± 9.97 |
63.52 ± 14.46 |
60.70 ± 10.06 |
68.37 ± 9.34 |
0.001 |
|
| Years since diagnosis* |
3.55 ± 3.19 |
4.73 ± 3.99 |
4.58 ± 4.07 |
2.95 ± 2.2 |
0.361 |
|
| Pre-therapeutic BMI (kg/m2)* |
29.20 ± 9.06 |
28.984 ± 8.41 |
27.49 ± 4.95 |
28.48 ± 5.89 |
0.576 |
|
| Post-therapeutic BMI (kg/m2)* |
27.54 ± 7.29 |
28.12 ± 6.59 |
27.16 ± 5.74 |
28.60 ± 5.49 |
0.577 |
|
| Correctly named diagnosis# |
22 (73,3) |
9 (42,9) |
24 (80) |
21 (70) |
0.008 |
|
| Educational level |
||||||
| No school graduation# |
1 (3.3) |
1 (4.8) |
0 |
1 (3.3) |
0.86 |
|
| Secondary school graduation# |
18 (60) |
16 (76.2) |
18 (60) |
21 (70) |
||
| High school graduation# |
4 (13.3) |
2 (9.5) |
3 (10) |
4 (13.3) |
||
| Academic degree# | 7 (23.3) | 2 (9.5) | 9 (30) | 4 (13.3) |
Values are provided as *mean ± standard deviation or #number (per cent). Parameters were tested using *Kruskal Wallis tests or #contingency tables.